Resmetirom Alternatives Compared
Resmetirom | Ursodiol | Pioglitazone |
|
---|
Resmetirom | Ursodiol | Pioglitazone |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Nonalcoholic Steatohepatitis. resmetirom may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Biliary Cholangitis , Nonalcoholic Steatohepatitis, Gallbladder Disease. ursodiol may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Diabetes - Type 2, Nonalcoholic Steatohepatitis. pioglitazone may also be used for purposes not listed in this medication guide. |
Related suggestions Nonalcoholic Steatohepatitis
|
|||||||||||||||
More about Resmetirom | More about Ursodiol | More about Pioglitazone | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Ursodiol has an average rating of 8.1 out of 10 from a total of 32 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 10% reported a negative effect. |
Pioglitazone has an average rating of 4.5 out of 10 from a total of 53 ratings on Drugs.com. 24% of reviewers reported a positive effect, while 51% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: resmetirom side effects in more detail. |
See also: ursodiol side effects in more detail. |
See also: pioglitazone side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all ursodiol prices |
View all pioglitazone prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Rezdiffra | Actigall, Reltone, Urso, Urso Forte | Actos | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
4.5 hours |
100 hours |
24 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 140 drugs are known to interact with resmetirom:
|
A total of 7 drugs are known to interact with ursodiol:
|
A total of 338 drugs are known to interact with pioglitazone:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
March 14, 2024 |
December 31, 1987 |
July 15, 1999 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.